Published on : Jan 18, 2019
Albany, New York, January 18, 2019: Backed by a robust pipeline of novel diagnostic systems as well as FDA approvals for a series of its diagnostic services, Abbott Diagnostics is estimated to sustain its leading stance on the back of sophisticated technologies, greater adoption by geriatric populace as well as rising mindfulness about the efficacy of diagnostic solutions. In its recent business intelligence report titled, 'Abbott Diagnostics - Product Pipeline Analysis, 2018 Update' Market Research Hub (MRH) evaluates Abbott Diagnostics' product pipeline.
New Diagnostics Systems to Rransform Influenza Diagnosis
Attaining accuracy and significantly high throughput remains a lingering challenge in diagnostics. To relieve this, Abbott Diagnostics has introduced its proprietary diagnostic system, Alinity series for enhanced clinical diagnostics outcome. The product is not available widely, however it has been launched in several regions such as the US. Alinity series is aimed to offer superlative results in the fields of clinical chemistry, immunoassays, hematology and the like. Additionally, In a significant development, Abbott Diagnostics has affirmed its FDA approval for advanced influenza test under the brands, Alere i Strep A2 for point of care diagnostics.
Abbott Diagnostics Product Pipeline: Report Scope
This elaborate research report on pipeline review of Abbott Diagnostics commences with an elaborate snapshot encompassing vital details on dynamics and trends that influence Abbott Diagnostics' investment strategies. Further, the report assesses Abbott Diagnostics' market position on the basis of crucial parameters such as its company overview, company facts and developments, product portfolio, range of diagnostic services, as well as recent developments in terms of strategic acquisitions, mergers, and new product launch.
Further in the course of the report, readers are also presented with vital market information on Abbott Diagnostic's geographical footprint, employee structure and subsidiaries. In-depth understanding on Abbott Diagnostics' existing portfolio as well as pipeline diagnostic services is aimed at offering report readers with ample competitive advantage besides enlightening readers with entry level barriers based on which aspiring market entrants as well as established entities can aptly deliver lucrative business decisions and investment plans to secure a leading stance amidst stiffening competition.
In its subsequent sections the report also analyzes Abbott Diagnostic's pipeline products, further diversifying pipeline products into broad segments for superlative understanding. By segments, Abbot Diagnostic's product pipeline is classified by equipment type, indication, development stage, and trial status. Further, the report also evaluates each of the pipeline product on the basis of pipeline territory, development stage, regulatory protocol, device class, applications as well as indications, besides including information on launch date estimations. Further, a dedicated chapter on clinical trials encompassing trial name, objective, design, and status has also been documented in the report to derive actionable business insights on product pipeline of Abbott Diagnostics.
Competitive Landscape: Abbott Diagnostics Product Pipeline
In its trailing sections the report also includes crucial details on existing competitive spectrum, highlighting potent competitors along with their company overview, portfolio diversification, winning tactical strategies, as well as recent developments in terms of new product addition, buy-outs, as well as strategic coalitions and product pipeline with their respective status and launch date.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=2027938
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : email@example.com